U.S. FDA flags data integrity, contamination lapses at Dabur's Dadra plant
After a January inspection, the U.S. drug regulator cited Dabur India for falsified records, microbial contamination risks, poor maintenance and even a live bird in the raw material warehouse at its Dadra and Nagar Haveli facility, raising compliance concerns for the 140-year-old FMCG major.
U.S. FDA flagged data integrity, contamination and maintenance lapses at Dabur India's Dadra and Nagar Haveli plant after a January inspection, citing falsified records, microbial contamination risks, and a live bird in the raw material warehouse.